|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA02000403
|
11OH-12,13-EpOME
|
11-hydroxy-(12S,13S)-epoxy-(9Z)-octadecenoic acid
|
FA 18:2;O2
|
C18H32O4
|
312.230060
|
|
LMFA02000404
|
11-oxo-12,13-EpOME
|
11-oxo-(12,13)-epoxy-(9Z)-octadecenoic acid
|
FA 18:3;O2
|
C18H30O4
|
310.214410
|
|
LMFA02000405
|
16-hydroxylinoleic acid
|
16-hydroxyoctadeca-9Z,12Z-dienoic acid
|
FA 18:2;O
|
C18H32O3
|
296.235145
|
|
LMFA02000406
|
11-Oxo-9(10)-EpOME
|
11-oxo-9,10-epoxy-(12Z)-octadecenoate
|
FA 18:3;O2
|
C18H30O4
|
310.214410
|
|
LMFA02000407
|
11-OH-9(10)-EpOME
|
11-hydroxy-9,10-epoxy-(12Z)-octadecenoate
|
FA 18:2;O2
|
C18H32O4
|
312.230060
|
|
LMFA02010024
|
Chromomoric acid
|
8-[5-hydroxy-4-oxo-5-[(Z)-pent-2-enyl]cyclopent-2-en-1-yl]octanoic acid
|
FA 18:4;O2
|
C18H28O4
|
308.198760
|
|
LMFA02010025
|
14,15-dehydro-12-oxo-phytodienoic acid
|
8-[(5E)-4-oxo-5-[(Z)-pent-2-enylidene]cyclopent-2-en-1-yl]octanoic acid
|
FA 18:5;O
|
C18H26O3
|
290.188195
|
|
LMFA01050601
|
9-Hydroxy-6Z-nonenoic acid
|
9-Hydroxy-6Z-nonenoic acid
|
FA 9:1;O
|
C9H16O3
|
172.109945
|
|
LMFA01170145
|
18-hydroxy-18-oxo-dinorleukotriene B4
|
(4Z,7R,8E,10E,12Z,14S)-7,14-dihydroxyoctadeca-4,8,10,12-tetraenedioic acid
|
FA 18:5;O4
|
C18H26O6
|
338.172940
|
|
LMFA03020086
|
Tauro-18-carboxy-19,20-dinorleukotriene B4
|
5S,12R-dihydroxy-18-oxo-18-(2-sulfoethylamino)octadeca-6Z,8E,10E,14Z-tetraenoic acid
|
|
C20H31NO8S
|
445.177041
|
|
LMFA01140107
|
Alutacenoic acid A
|
6-(3-oxocyclopropen-1-yl)hexanoic acid
|
FA 9:3;O
|
C9H12O3
|
168.078645
|
|
LMFA01140108
|
Alutacenoic acid B
|
8-(3-oxocyclopropen-1-yl)octanoic acid
|
FA 11:3;O
|
C11H16O3
|
196.109945
|
|
LMFA01050602
|
2R-hydroxy-goshuyic acid
|
2R-hydroxy-5Z,8Z-tetradecadienoic acid
|
FA 14:2;O
|
C14H24O3
|
240.172545
|
|
LMFA07100007
|
methyl-2R-hydroxy-goshuyic acid
|
methyl 2R-hydroxy-5Z,8Z-tetradecadienoate
|
SFE 15:2;O
|
C15H26O3
|
254.188195
|
|
LMFA01140109
|
Tripmycin A
|
13-(2-methylphenyl)-12E-tridecenoic acid
|
FA 20:5
|
C20H30O2
|
302.224580
|
|
LMFA01140110
|
|
5-(2-Methylphenyl)-4-pentenoic acid
|
FA 12:5
|
C12H14O2
|
190.099380
|
|
LMFA01050603
|
20-HEPE
|
(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoic acid
|
FA 20:5;O
|
C20H30O3
|
318.219495
|
|
LMFA01050604
|
22-HDHA
|
22-hydroxy-4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid
|
FA 22:6;O
|
C22H32O3
|
344.235145
|
|
LMFA07070120
|
3S,7Z-hydroxytetradecenoylcarnitine
|
3-{[(7Z)-3-hydroxytetradec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 14:1;O
|
C21H39NO5
|
385.282824
|
|
LMFA07070121
|
3S,5Z-hydroxydodecenoylcarnitine
|
3S-{[(5Z)-3-hydroxydodec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 12:1;O
|
C19H35NO5
|
357.251524
|
|
LMFA07070122
|
2E,9Z-Hexadecadienoylcarnitine
|
3-[(2E,9Z)-hexadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:2
|
C23H41NO4
|
395.303559
|
|
LMFA07070123
|
2E,7Z-tetradecadienoylcarnitine
|
3-[(2E,7Z)-tetradeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:2
|
C21H37NO4
|
367.272259
|
|
LMFA07070124
|
2E,5Z-dodecadienoylcarnitine
|
3-[(2E,5Z)-dodeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 12:2
|
C19H33NO4
|
339.240959
|
|
LMFA07070125
|
2E,9Z-Octadecadienoylcarnitine
|
3-[(2E,9Z)-octadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 18:2
|
C25H45NO4
|
423.334859
|
|
LMFA07070126
|
7Z-Hexadecenoylcarnitine
|
3-[(7Z)-hexadeca-7-enoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:1
|
C23H43NO4
|
397.319209
|
|
LMFA07070127
|
2E,7Z-Hexadecadienoylcarnitine
|
3-[(2E,7Z)-hexadeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:2
|
C23H41NO4
|
395.303559
|
|
LMFA07070128
|
(7Z)-3S-hydroxyhexadecenoylcarnitine
|
3S-{[(7Z)-3-hydroxyhexadec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 16:1;O
|
C23H43NO5
|
413.314124
|
|
LMFA07070129
|
(5Z)-3S-hydroxytetradecenoylcarnitine
|
3S-{[(5Z)-3-hydroxytetradec-5-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 14:1;O
|
C21H39NO5
|
385.282824
|
|
LMFA07070130
|
2E,5Z-tetradecadienoylcarnitine
|
3-[(2E,5Z)-tetradeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:2
|
C21H37NO4
|
367.272259
|
|
LMFA07070134
|
2E,decenoylcarnitine
|
3-[(2E-decenoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 10:1
|
C17H31NO4
|
313.225309
|
|
LMFA07070133
|
3S-hydroxyoctanoylcarnitine
|
3S-{[-3-hydroxyoctanoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 8:0;O
|
C15H29NO5
|
303.204574
|
|
LMFA07070132
|
3S-hydroxydecanoylcarnitine
|
3S-{[-3-hydroxydecanoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 10:0;O
|
C17H33NO5
|
331.235874
|
|
LMFA07070131
|
3S-hydroxyhexadecanoylcarnitine
|
3S-{[-3-hydroxyhexadecanoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 16:0;O
|
C23H45NO5
|
415.329774
|
|
LMFA02000412
|
13S-HOME(9Z)
|
13S-hydroxy-9Z-octadecenoic acid
|
FA 18:1;O
|
C18H34O3
|
298.250795
|
|
LMFA03050032
|
11,12,15-THETA
|
11,12,15-trihydroxy-5Z,8Z,13E-eicosatrienoic acid
|
FA 20:3;O3
|
C20H34O5
|
354.240625
|
|
LMFA02030075
|
Callicarboric acid A
|
Methyl (1R,2R)-4-oxo-5-(2-oxo-3E-pentenyl)-2-cyclopentene-1-octanoate
|
FA 19:5;O2
|
C19H28O4
|
320.198760
|
|
LMFA02030076
|
Callicarboric acid B
|
Methyl (1S,2R)-4-oxo-5-(methyl acetoyl)-2-cyclopentene-1-octanoate
|
FA 17:4;O3
|
C17H26O5
|
310.178025
|
|
LMFA01020445
|
|
(Z)-13-Methyltetradec-4-enoic acid
|
FA 15:1
|
C15H28O2
|
240.208930
|
|
LMFA01060242
|
15Z-Insignoic acid A
|
6-hydroxy-4-oxotetracosa-2E,15Z-dienoic acid
|
FA 24:3;O2
|
C24H42O4
|
394.308310
|
|
LMFA01060243
|
16Z-Insignoic acid A
|
6-hydroxy-4-oxotetracosa-2E,16Z-dienoic acid
|
FA 24:3;O2
|
C24H42O4
|
394.308310
|
|
LMFA01060244
|
17Z-Insignoic acid A
|
6-hydroxy-4-oxotetracosa-2E,17Z-dienoic acid
|
FA 24:3;O2
|
C24H42O4
|
394.308310
|
|
LMFA01060245
|
15Z-Insignoic acid B
|
4-oxotetracosa-2E,5E,15Z-trienoic acid
|
FA 24:4;O
|
C24H40O3
|
376.297745
|
|
LMFA01060246
|
16Z-Insignoic acid B
|
4-oxotetracosa-2E,5E,16Z-trienoic acid
|
FA 24:4;O
|
C24H40O3
|
376.297745
|
|
LMFA01060247
|
17Z-Insignoic acid B
|
4-oxotetracosa-2E,5E,17Z-trienoic acid
|
FA 24:4;O
|
C24H40O3
|
376.297745
|
|
LMFA01060248
|
18Z-Insignoic acid B
|
4-oxotetracosa-2E,5E,18Z-trienoic acid
|
FA 24:4;O
|
C24H40O3
|
376.297745
|
|
LMFA01060249
|
19Z-Insignoic acid B
|
4-oxotetracosa-2E,5E,19Z-trienoic acid
|
FA 24:4;O
|
C24H40O3
|
376.297745
|
|
LMFA01060250
|
21Z-Insignoic acid B
|
4-oxotetracosa-2E,5E,21Z-trienoic acid
|
FA 24:4;O
|
C24H40O3
|
376.297745
|
|
LMFA01060251
|
15Z-Insignoic acid C
|
6-ethoxy-4-oxotetracosa-2E,15Z-dienoic acid
|
FA 26:3;O2
|
C26H46O4
|
422.339610
|
|
LMFA01060252
|
16Z-Insignoic acid C
|
6-ethoxy-4-oxotetracosa-2E,16Z-dienoic acid
|
FA 26:3;O2
|
C26H46O4
|
422.339610
|
|
LMFA01060253
|
17Z-Insignoic acid C
|
6-ethoxy-4-oxotetracosa-2E,17Z-dienoic acid
|
FA 26:3;O2
|
C26H46O4
|
422.339610
|